Antibiotic management of drug resistant infections: A survey of clinical practice

Participate in a short 5-7 minute online survey of the most likely clinical management of patients with drug resistant infections within your facility. Information on the management of the following pathogenic bacteria is requested:
1. E.coli resistant to third-generation cephalosporin.
2. K. pneumoniae resistant to third-generation cephalosporin.
3. Ceftazidime-resistant P. aeruginosa.
4. Vancomycin-resistant E. faecium.

This survey forms part of a larger research study conducted by researchers from the School of Public Health and Social Work, Queensland University of Technology (QUT), termed “The Health Economic Modelling of Antimicrobial resistance in Australia”, which aims to determine the health and economic burden of key resistant organisms which have shown to be of importance in Australia.

Your participation in this project is entirely voluntary. If you agree to participate you do not have to complete any question(s) you are uncomfortable answering.

Please find the Participant Information Sheet
The link to the online survey is:

Should you have any concerns or questions about this survey, please feel free to contact Dr Teresa Wozniak via email

The survey will run from 11 January 2017 until 11 February 2017.

By participating in this survey you will be making an important contribution to a better understanding of how patients with resistant infections are being managed and in doing so improve more broadly our understanding of the burden of antimicrobial resistance in Australia.


Wozniak TM (2017) Clinical management of drug-resistant bacteria in Australian hospitals: an online survey of doctors' opinions. Infection, Disease & Health (forthcoming)


Dr Teresa Wozniak